The global intravenous pegloticase market is poised for substantial growth, projected to reach USD 11.61 Billion by 2033 from ...

With the clinical development of XORLO TM1 having advanced sufficiently, including completion of a pivotal program, XORTX is initiating discussions for the XRx-026 program with the US Food and Drug ...

Gout Gout, a 17-year-old from Queensland, has become one of the most talked about sprinters on the planet after breaking the ...

The Mediterranean diet wins U.S. News & World Report's 2025's "best of the best" award for wellness. Diets were rated on a ...

Nigeria’s youngster, Samuel Ogazi, has been picked as one of the emerging sprint talents to watch in 2025. According to ...

The following is a summary of “Improving Gout Care in a Canadian Academic Medical Center Through a Multidisciplinary ...

Colchicine prophylaxis during initiation of urate-lowering therapy in patients with gout was associated with a reduced risk ...

A recent study in ACR Open Rheumatology identified which patients were most likely to underreport experiencing or ...

World Athletics President Sebastian Coe says his sport enjoyed a stellar 2024 and is on an upward curve in terms of ...

For gout, xanthine oxidase (XO) inhibitors are the choice for first-line urate-lowering therapy (ULT) according to the 2020 American College of Rheumatology Guideline for the Management of Gout ...

Gout Gout's father recently clarified his opinion on the mix-up of his son's name. The sprinter's father voiced his disapproval in the wake of his son's incredible run in the last few days ...